At present, recombinant human growth hormone and alginate dressing have been used in clinical treatment of diabetic foot ulcer, but due to the lack of high quality, multi-level, and multi-angle clinical trial supporting, so the effectiveness and safety of recombinant human growth hormone and alginate dressing in DFU patients is still controversial. The gene discussed is GH1; the disease is diabetic foot.